Skip to main content
. 2019 Sep 22;7(4):51. doi: 10.3390/toxics7040051

Table 1.

Composition of polymeric nanocapsules (NCs).

Formulation F1 *
[wt.%]
F2 **
[wt.%]
Organic Phase
Poly(ε-caprolactone) 0.017 0.017
Carrot oil 0.005 0.005
Benzophenone-3 0.0005 -
Acetone 10 10
Aqueous phase
Pluronic® F68 0.02 0.02
Distilled water (q.s.) 20 mL 20 mL

* F1—Formulation no. 1 containing BZP3; ** F2—Formulation no. 2 without BZP3.